Leidos awarded Medicaid Enterprise Systems Integrator contract

News provided by

Jul 09, 2024, 08:00 ET

RESTON, Va., July 9, 2024 /PRNewswire/ -- Leidos (NYSE: LDOS), a Fortune® 500 innovation company, has been awarded the Medicaid Enterprise Systems Integrator contract by North Dakota Health and Human Services. Leidos will provide systems integration support to transition North Dakota's existing Medicaid Management Information Systems to an integrated, scalable, and secure modular system.

"Transitioning North Dakota's legacy Medicaid systems to a modern system will help provide a better healthcare experience for patients, providers and administrators," said Liz Porter, Leidos Health & Civil Sector President. "Building on our strength of innovation and proven expertise in technology modernization, we look forward to delivering tailored solutions that empower data-driven decision making. This modernization project will help position North Dakota to embrace and harness future advancements."

Leidos will support North Dakota's goals of improving health outcomes and ensuring efficient, effective, and economical management of its Medicaid program through Medicaid Enterprise Systems (MES) modernization. MES involves a comprehensive set of technologies and solutions that manage and administer benefits in compliance with federal and state regulations. Leidos will collaborate with North Dakota Health and Human Services to meet the unique challenges of modernizing MES, optimizing data management, ensuring interoperability, and executing seamless transition.

To learn more, read about Leidos' Medicaid systems solutions or visit www.leidos.com/civilian-health.

About Leidos

Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 47,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $15.4 billion for the fiscal year ended December 29, 2023. For more information, visit www.leidos.com.

Certain statements in this announcement constitute "forward-looking statements" within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management's current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the "Risk Factors" set forth in Leidos' Annual Report on Form 10-K for the fiscal year ended December 29, 2023, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.

Contact:

Melissa Dueñas
(571) 526-6850
[email protected]

Alyssa Pettus
(571) 526-6743
[email protected]

Brandon Ver Velde
(571) 526-6257
[email protected]

SOURCE Leidos Holdings, Inc.